HealthDay - WEDNESDAY, Oct. 5 (HealthDay News) -- Treating women with an aggressive form of early stagebreast cancer using Herceptin and chemotherapy, while not turning to a third type of drug known as an anthracycline, improves survival while posing less danger to the heart, researchers report.
More...
More...